September 22, 2021
Corporate sponsorship to support IDEOM for 2022 is now open!
We respectfully request your corporate sponsorship support. The Corporate sponsorship packages are outlined in this application and are valid for one year (2022). The date of the annual meeting for 2022 will be determined.
International Dermatology Outcome Measures (IDEOM) is working to establish patient-centered measurements to enhance research and treatment of those with dermatological diseases. Our priority is to create meaningful endpoints for use in clinical trials and that can carry-over into clinical practice, taking into account the needs of patients, providers, researchers, payers and regulators.
IDEOM recognize the inconsistency and unmet needs in current tools and measurements, and together relevant stakeholders, including clinicians, methodologists, patients, pharmaceutical colleagues, insurers, regulatory agencies and policy regulators, our goal is to address these gaps in clinical end points.
We thank you for your consideration and hope to see you at the annual meeting, where the voice of our industry stakeholders is important.
IDEOM Association Manager